Global Ferritin Testing Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029
Market Overview:
The latest research study on the global Ferritin Testing market finds that the global Ferritin Testing market reached a value of USD 379.63 million in 2022. It’s expected that the market will achieve USD 469.42 million by 2028, exhibiting a CAGR of 3.6% during the forecast period.
Influence of COVID-19 Outbreak on Ferritin Testing Industry Development
Doctors use ferritin blood tests to check the iron content in a person's blood and help diagnose many health conditions as part of a human health check. There is currently no evidence that COVID-19 virus affects ferritin levels. However, the outbreak of an epidemic virus has affected the medical systems of many countries, including developed countries including Italy, Spain, and the United States. Medical resources have begun to be scarce and hospitals have difficulty operating properly. In the short-term, affected by the epidemic, the ferritin test market may shrink as people begin to reduce the number of trips to prevent infection. In the long run, the ferritin test market is weakly affected by COVID-19.
Market Challenges
Medical resources are often severely inadequate in low-income countries and poor areas of developing countries. Many people have developed symptoms of iron deficiency or high iron, but they are not well tested and treated due to low income and limited medical resources. Poverty, malnutrition and famine are the causes of anemia in a large number of people with iron deficiency in developing countries, especially children and pregnant women. Lower ferritin test rates in low-income areas are limiting market expansion.
The market launch of medical products often requires complex development and testing procedures, which is a large overhead. With the improvement of the medical system, countries are strengthening the supervision of medical products. This puts forward higher requirements for manufacturers' product quality control. And there have been many recalls of related products before because of quality problems, which may have an adverse impact on the development of the industry.
Region Overview:Europe had the highest growth rate of all regions.
Company Overview:The top three companies are Roche, Abbott, Siemens with the revenue market share of 19.89%, 18.19% and 14.85% in 2019.
Roche is a multinational pharmaceutical R&D manufacturer based in Basel, Switzerland. Today, Roche has created innovative drug and diagnostic tests that help millions of patients around the world.
With a focus on pharmaceuticals, medical devices and nutritional products, Abbott is a multinational company with more than 72,000 employees.
Segmentation Overview:Among different product types, Serum Sample segment is anticipated to contribute the largest market share in 2028.
Application Overview:By application, the Diagnostic or Therapeutic segment occupied the biggest share from 2018 to 2022.
Key Companies in the global Ferritin Testing market covered in Chapter 3:Wuhan Easy Diagnosis
Roche
Eurolyser Diagnostica
Boditech Med Inc.
Abnova Corporation
Tosoh Bioscience
Siemens
Biopanda Reagents
Monobind
Beckman Coulter
Abbott
Doctorcall
Ortho Clinical Diagnostics
bioMérieux
DiaSorin
Humankind Ventures Ltd.
In Chapter 4 and Chapter 14.2, on the basis of types, the Ferritin Testing market from 2018 to 2029 is primarily split into:Serum Sample
Plasma Sample
Others
In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Ferritin Testing market from 2018 to 2029 covers:Research
Diagnostic or Therapeutic
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)